Article
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2013
Mondul Alison M, Shui Irene M, Yu Kai, Travis Ruth C, Stevens Victoria L, Campa Daniele, Schumacher Frederick R, Ziegler Regina G, Bueno-de-Mesquita H Bas, Berndt Sonja, Crawford E D, Gapstur Susan M, Gaziano J Michael, Giovannucci Edward, Haiman Christopher A, Henderson Brian E, Hunter David J, Johansson Mattias, Key Timothy J, Le Marchand Loïc, Lindström Sara, McCullough Marjorie L, Navarro Carmen, Overvad Kim, Palli Domenico, Purdue Mark, Stampfer Meir J, Weinstein Stephanie J, Willett Walter C, Yeager Meredith, Chanock Stephen J, Trichopoulos Dimitrios, Kolonel Laurence N, Kraft Peter, Albanes Demetrius
Abstract excerpt
BACKGROUND: Studies suggest that vitamin D status may be associated with prostate cancer risk although the direction and strength of this association differs between experimental and observational studies. Genome-wide association studies have identified genetic variants associated with 25-hydroxyvitamin D [25(OH)D] status. We examined prostate cancer risk in relation to single-nucleotide polymorphisms (SNP) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.